Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Chronic Kidney Diseases Patients With Persistent Proteinuria

NCT00858299 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT00858299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00858299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Chronic Kidney Diseases Patients With Persistent Proteinuria
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2009
Completion date
December 31, 2011
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, proteinuria